Elafibranor 80mg tablets
NHS hospitals in England used £21,120,902 of indicative cost of Elafibranor 80mg tablets in the 12 months to July 2026, about 0.1% of all hospital medicines spend. That is up 262.4% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Elafibranor 80mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Elafibranor 80mg tablets most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Bradford Teaching Hospitals Nhs Ft | £7,563,146 |
| Royal Free London Nhs Foundation Trust | £1,126,731 |
| Royal Surrey County Hosp Nhs Found Trust | £1,123,864 |
| King's College Hpl Nhs Foundation Trust | £1,063,657 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £1,026,386 |
| Aintree University Hospital Nhs Ft | £788,425 |
| Nottingham University Hospitals Trust | £776,957 |
| Sheffield Teaching Hospitals Nhs Trust | £742,553 |
| Manchester University Nhs Ft | £688,080 |
| Hull And East Yorkshire Hpls Nhs Trust | £642,208 |
The primary-care picture
Elafibranor is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Elafibranor medicine page.